The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost. This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning-based technologies / solutions within the healthcare industry.